Phase II Randomized Trial Comparing Weekly Administration of Taxol with Carboplatin to an Every 3 Week Regimen for the Treatment of Advanced Stage IIIB/IV Non-Small Cell Lung Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date10/8/0210/31/04

Funding

  • Bristol Myers Squibb Company: $6,300.00